Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth NAV today
AMFI: 153023ISIN: INF247L01EA7MUTF_IN: MOTI_OSWA_NIFT_1V0RMRNMotilal Oswal Mutual FundIndex funds
NAV ₹11.5002down ₹0.14 (1.19%)
NAV for 23 Oct 2026, against 22 Oct 2026. Declared once a day.
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month.
- ₹53 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it.
- 0.80%15 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought.
- 1%if sold within 15 days
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot make the fund look cheap. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted.
- 39.630 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures.
- 3030 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer.
- 19 Nov 2024
Motilal Oswal Nifty MidSmall Healthcare Index Fund returns
Direct Growth plan
Over each window to 23 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. | Rank in categoryRank in category. The fund's place among the funds of its category with a return over the same window, highest return first. | Category medianCategory median. The middle return of the funds in the category over the same window: half returned more, half less. | Middle halfMiddle half of the category. The returns of the fund a quarter of the way down the category and the fund a quarter of the way up, over the same window: half the category's funds returned between the two. |
|---|---|---|---|---|---|
| 1 week | −3.35% | −3.34% | – | – | – |
| 1 month | −10.45% | −10.40% | 3 of 3 | −10.42% | −10.4% to −10.2% |
| 3 months | −5.47% | −5.29% | 2 of 3 | −5.47% | −8.3% to −5.4% |
| 6 months | +5.53% | +5.96% | 2 of 3 | +5.53% | +2.8% to +5.6% |
| 1 year | +7.01% | +7.81% | 2 of 3 | +7.01% | −4.6% to +7.1% |
| 3 years | Needs 3 years | – | – | – | – |
₹10,000 put in on 25 Nov 2024 is ₹11,304 at the NAV of 23 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load.Over a year and longer, a return is the yearly rate. Benchmark: Nifty MidSmall Healthcare TRI, over the same days as the fund. Rank, median and middle half among the Direct plans of funds tracking Nifty MidSmall Healthcare, each fund's return to its latest NAV on or before 25 Oct 2026.
At the month end, 30 Sep 2026
| Over | FundTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. |
|---|---|---|
| 1 year | +17.71% | +18.60% |
| Since launch | +11.80% | +12.62% |
Benchmark: Nifty MidSmall Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Direct GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Nifty MidSmall Healthcare TRIBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer.
- Loss
Motilal Oswal Nifty MidSmall Healthcare Index Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 23 Oct 2026
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,23,572₹1,23,566 after stamp duty | +5.82% | +5.81% | ₹6 | |
| Since Nov 202423 instalments | ₹2,30,000 | ₹2,48,095₹2,48,083 after stamp duty | +7.98% | +7.97% | ₹12 |
3 years: Launched 19 Nov 2024, needs 3 years of history.
Tracking error
Against Nifty MidSmall Healthcare TRI, as on 30 Sep 2026.
Against its index, by window
| Measure | Direct, this plan | Regular |
|---|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. | 0.04% | 0.05% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. | −0.89 pts | −1.42 pts |
| Difference since launch | −0.82 pts | −1.33 pts |
Difference: the fund's return less the index's, in percentage points.
Motilal Oswal Nifty MidSmall Healthcare Index Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio.
- 0.42 ptsA year, on 15 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 0.80%Over the last 30 days filed
- Regular, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 1.22%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan at its highest since Nov 2024 in the latest month.Direct plan lowest 0.50%, Dec 2024.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. | 0.54% | 0.90% |
| Brokerage | 0.02% | 0.02% |
| Transaction costs | None | None |
| Statutory levies | 0.24% | 0.30% |
Per cent of assets a year, filed for 15 Oct 2026. The parts add up to that day's total.
Exit load, in the fund house's words
1%- If redeemed on or before 15 days from the date of allotment. Nil- If redeemed after 15 days from the date of allotment
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase.
- ₹500
- Minimum top-up
- ₹500
- Minimum redemption
- ₹500
- SIP
- Accepted
- SIP minimum
- ₹100
- SIP instalments, at least
- 1 month (30 days)
- SIP dates
- Any Day
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold.
- None
As listed for this plan on 24 Oct 2026.
Motilal Oswal Nifty MidSmall Healthcare Index Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹48 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors.
- 64.4%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Dec 2024.
Assets at each month end
The latest month end is the highest since Apr 2025.Lowest ₹24 Cr, Jun 2025.
Motilal Oswal Nifty MidSmall Healthcare Index Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. | |||
|---|---|---|---|---|---|
| Laurus LabsPharmaceuticals & Biotechnology | Mid cap171st | 11.83% | 6.22 | 31,389 | Nov 2024or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 7.57% | 3.97 | 19,577 | Nov 2024or earlier |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 7.09% | 3.72 | 22,273 | Nov 2024or earlier |
| Fortis HealthcareHealthcare Services | Mid cap156th | 6.15% | 3.23 | 41,993 | Nov 2024or earlier |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap176th | 5.39% | 2.83 | 12,134 | Nov 2024or earlier |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Mid cap164th | 4.78% | 2.51 | 4,860 | Nov 2024or earlier |
| Mankind PharmaPharmaceuticals & Biotechnology | Mid cap119th | 4.35% | 2.29 | 9,133 | Nov 2024or earlier |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | Mid cap229th | 4.11% | 2.16 | 11,197 | Nov 2024or earlier |
| BioconPharmaceuticals & Biotechnology | Mid cap173rd | 3.96% | 2.08 | 56,168 | Nov 2024or earlier |
| Gland PharmaPharmaceuticals & Biotechnology | Small cap261st | 3.54% | 1.86 | 6,423 | Nov 2024or earlier |
| Sai Life SciencesPharmaceuticals & Biotechnology | Small cap329th | 3.23% | 1.70 | 11,147 | Mar 2026 |
| Krishna Institute of Medical SciencesHealthcare Services | Small cap285th | 3.06% | 1.61 | 21,508 | Nov 2024or earlier |
| Aster DM Quality CareHealthcare Services | Mid cap244th | 2.86% | 1.50 | 21,543 | Nov 2024or earlier |
| Neuland LaboratoriesPharmaceuticals & Biotechnology | Small cap356th | 2.82% | 1.48 | 695 | Mar 2025 |
| WockhardtPharmaceuticals & Biotechnology | Small cap311th | 2.68% | 1.41 | 6,658 | Sep 2025 |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | ||
|---|---|---|
| Net Receivables / (Payables) | −0.83% | −0.43 |
| Triparty Repo | 0.76% | 0.40 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions.
- 11.83%Laurus Labs
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions.
- 38.03%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions.
- 58.77%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights.
- 20.2Taken over 100.07% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought.- Indian shares100.07%
- Cash and receivables−0.07%
Per cent of the fund's net assets.
Large, mid and small cap
Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month.- Large capNone
- Mid cap67.82%
- Small cap32.18%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets.1sector
- Healthcare100.07%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare30 companies | 100.07% | 100.31% | 99.76% | 100.28% | 99.92% | 100.04% | 99.81% | 99.84% | 99.73% | 99.80% | 99.84% | 99.88% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before.
- 11.42% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date.
- 11.07% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth.
- 29
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth.
- 0
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price.
- 0
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month.
- 1.07%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it.
- 4.09%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. | ||||
|---|---|---|---|---|---|
| Anthem Biosciences | New | 1.42% | 0.00% | +1.42 pts | +8,696 |
| Pfizer | Sold out | – | 1.07% | −1.07 pts | −1,160 |
| Fortis Healthcare | Added | 6.15% | 7.12% | −0.97 pts | +2,104 |
| Laurus Labs | Added | 11.83% | 11.23% | +0.60 pts | +1,607 |
| Biocon | Added | 3.96% | 4.43% | −0.47 pts | +1,557 |
| Lupin | Added | 7.57% | 8.01% | −0.44 pts | +988 |
| Wockhardt | Added | 2.68% | 2.34% | +0.34 pts | +337 |
| Ajanta Pharma | Added | 2.53% | 2.29% | +0.24 pts | +450 |
| Glenmark Pharmaceuticals | Added | 5.39% | 5.63% | −0.24 pts | +609 |
| Mankind Pharma | Added | 4.35% | 4.11% | +0.24 pts | +496 |
| Sai Life Sciences | Added | 3.23% | 3.03% | +0.20 pts | +586 |
| Aster DM Quality Care | Added | 2.86% | 3.05% | −0.19 pts | +1,079 |
| Neuland Laboratories | Added | 2.82% | 2.99% | −0.17 pts | +35 |
| Abbott India | Added | 2.17% | 2.03% | +0.14 pts | +21 |
| Acutaas Chemicals | Added | 2.61% | 2.47% | +0.14 pts | +212 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Laurus Labs | 6.91%Cut | 7.43%Cut | 7.98%Cut | 7.25%Cut | 7.68%Added | 7.34%Added | 7.57%Added | 8.82%Added | 9.31%Added | 10.77%Added | 11.23%Added | 11.83%Added |
 Lupin | 8.83%Cut | 9.33%Cut | 9.48%Cut | 10.09%Cut | 10.25%Added | 10.67%Added | 9.88%Added | 9.15%Added | 9.26%Added | 8.94%Added | 8.01%Added | 7.57%Added |
 Aurobindo Pharma | 5.94%Cut | 6.36%Cut | 6.14%Cut | 6.53%Cut | 6.27%Added | 6.93%Added | 6.87%Added | 6.63%Added | 6.89%Added | 6.66%Added | 7.16%Added | 7.09%Added |
 Fortis Healthcare | 9.91%Cut | 8.87%Cut | 8.54%Cut | 8.57%Cut | 9.02%Added | 7.87%Added | 8.50%Added | 8.05%Added | 7.86%Added | 7.50%Added | 7.12%Added | 6.15%Added |
 Glenmark Pharmaceuticals | 5.29%Cut | 5.43%Cut | 5.68%Cut | 5.87%Cut | 5.91%Added | 6.10%Added | 6.40%Added | 5.69%Added | 5.23%Added | 5.13%Added | 5.63%Added | 5.39%Added |
 Alkem Laboratories | 5.78%Cut | 5.94%Cut | 5.98%Added | 6.42%Cut | 6.06%Added | 5.89%Added | 5.58%Added | 5.34%Added | 5.14%Added | 5.13%Added | 4.70%Added | 4.78%Added |
 Mankind Pharma | 5.01%Cut | 4.72%Cut | 4.61%Cut | 4.64%Cut | 4.67%Added | 4.31%Added | 4.49%Added | 4.47%Added | 4.54%Added | 4.26%Added | 4.11%Added | 4.35%Added |
 IPCA Laboratories | 3.29%Cut | 3.75%Cut | 3.66%Cut | 3.95%Cut | 3.90%Added | 4.23%Added | 3.76%Added | 3.52%Added | 3.72%Added | 3.70%Added | 4.13%Added | 4.11%Added |
 Biocon | 4.17%Cut | 4.44%Cut | 4.39%Cut | 5.06%Added | 5.11%Added | 4.90%Added | 4.54%Added | 5.09%Added | 4.70%Added | 4.63%Added | 4.43%Added | 3.96%Added |
 Gland Pharma | 2.86%Cut | 2.60%Cut | 2.54%Cut | 2.84%Cut | 2.66%Added | 2.57%Added | 2.46%Added | 2.98%Added | 3.13%Added | 3.04%Added | 3.46%Added | 3.54%Added |
 Sai Life Sciences | – | – | – | – | – | 2.54%Bought | 2.60%Added | 2.65%Added | 2.68%Added | 2.76%Added | 3.03%Added | 3.23%Added |
 Krishna Institute of Medical Sciences | 3.31%Cut | 3.13%Cut | 2.79%Cut | 2.88%Cut | 3.38%Added | 2.92%Added | 2.91%Added | 3.12%Added | 3.33%Added | 3.18%Added | 2.95%Added | 3.06%Added |
 Aster DM Quality Care | 2.86%Cut | 2.79%Cut | 2.66%Cut | 2.48%Cut | 2.80%Added | 3.22%Added | 3.14%Added | 3.07%Added | 3.13%Added | 3.17%Added | 3.05%Added | 2.86%Added |
 Neuland Laboratories | 2.62%Cut | 2.75%Cut | 2.41%Cut | 2.20%Cut | 2.02%Added | 1.97%Added | 2.28%Added | 2.42%Added | 2.53%Added | 2.50%Added | 2.99%Added | 2.82%Added |
 Wockhardt | 1.97%Cut | 1.89%Cut | 2.22%Cut | 2.21%Cut | 2.07%Added | 1.85%Added | 2.04%Added | 2.79%Added | 2.53%Added | 2.47%Added | 2.34%Added | 2.68%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it.
Highest 54.0% in Jan 2026
Risk ratios
NAV to 23 Oct 2026
Each bar runs from the lowest to the highest figure among the Direct plans of funds tracking Nifty MidSmall Healthcare (3 funds) over the same 1 year; the tick is their average and the dot this fund.
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves.14.95%
14.95%Lowest21.74%Average35.31%Highest
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure.8.15%
8.14%Lowest12.93%Average22.51%Highest
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV.0.82
−0.05Lowest0.53Average0.83Highest
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down.1.36
−0.07Lowest0.89Average1.38Highest
Against Nifty MidSmall Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less.1.00
1.00Lowest1.30Average1.91Highest
AlphaAlpha. The yearly return the fund made beyond what its beta to the benchmark accounts for.−0.86 pts
−32.62 ptsLowest−11.39 ptsAverage−0.67 ptsHighest
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100.100.0
65.7Lowest88.6Average100.0Highest
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together).1.00
0.81Lowest0.94Average1.00Highest
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months.98.3%
98.3%Lowest107.5%Average125.5%Highest
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months.Needs 6 falling months
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. |
|---|---|---|---|---|
| 1 year | −10.45% | 23 Sep 2026 | 23 Oct 2026 | Not yet |
| Since Nov 2024 | −17.48% | 7 Jan 2025 | 28 Feb 2025 | 15 Jul 2025 |
Risk level by month
| Months | FundRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. |
|---|---|---|
| Mar 2025 to Aug 202618 months | Very High | Very HighNifty MidSmall Healthcare TRI |
| Feb 20251 month | Very High | Nifty MidSmall Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Motilal Oswal Nifty MidSmall Healthcare Index Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. | ||
|---|---|---|---|---|---|---|---|---|
| Swapnil MayekarPrimary; For Equity Component | Nov 2024 | +8.64%a year | +9.42% | −0.77 pts | – | – | 28 | ₹31,909 Cr₹12,778 Cr alone |
| Rakesh ShettyPrimary; For Debt Component | Nov 2024 | +8.64%a year | +9.42% | −0.77 pts | – | – | 39 | ₹85,523 Cr₹4,586 Cr alone |
Returns are the direct plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | ||
|---|---|---|---|---|---|
| Motilal Oswal Nasdaq 100 Fund of FundSwapnil Mayekar | Nov 2018 | +26.50%a year | – | – | ₹8,032 Cr |
| Motilal Oswal Nifty India Defence Index FundSwapnil Mayekar | Jul 2024 | +5.24%a year | +5.82% | −0.59 pts | ₹5,434 Cr |
| Motilal Oswal Nifty Midcap 150 Index FundSwapnil Mayekar | Sep 2019 | +21.04%a year | +21.32% | −0.28 pts | ₹3,995 Cr |
| Motilal Oswal Nifty 500 Index FundSwapnil Mayekar | Sep 2019 | +14.28%a year | +14.73% | −0.44 pts | ₹3,086 Cr |
| Motilal Oswal Nifty Microcap 250 Index FundSwapnil Mayekar | Jun 2023 | – | – | – | ₹2,410 Cr |
| Motilal Oswal BSE Enhanced Value Index FundSwapnil Mayekar | Aug 2022 | +24.56%a year | – | – | ₹2,132 Cr |
| Motilal Oswal Nifty Smallcap 250 Index FundSwapnil Mayekar | Sep 2019 | +21.00%a year | +21.76% | −0.76 pts | ₹1,243 Cr |
| Motilal Oswal Nifty 200 Momentum 30 Index FundSwapnil Mayekar | Feb 2022 | +8.95%a year | +9.65% | −0.69 pts | ₹882 Cr |
| Motilal Oswal Nifty 50 Index FundSwapnil Mayekar | Dec 2019 | +11.08%a year | +11.25% | −0.17 pts | ₹845 Cr |
| Motilal Oswal Nifty 500 Momentum 50 Index FundSwapnil Mayekar | Sep 2024 | −9.63%a year | −8.95% | −0.68 pts | ₹785 Cr |
Up to ten funds a manager, largest first. Returns are the direct plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | Shared holdings. The number of securities both funds hold, cash and futures left out. | |
|---|---|---|
| Tata Nifty MidSmall Healthcare Index FundTata Mutual Fund | 99.96% | 30 |
| ICICI Prudential Nifty Pharma Index FundICICI Prudential Mutual Fund | 43.09% | 14 |
| Bandhan BSE Healthcare Index FundBandhan Mutual Fund | 40.75% | 30 |
| DSP Nifty Healthcare Index FundDSP Mutual Fund | 36.88% | 12 |
| Edelweiss Msci India Domestic & World Healthcare 45 Index FundEdelweiss Mutual Fund | 27.58% | 17 |
| Kotak Nifty Smallcap 50 Index FundKotak Mahindra Mutual Fund | 18.12% | 10 |
| Kotak Nifty Midcap 150 Momentum 50 Index FundKotak Mahindra Mutual Fund | 17.33% | 7 |
| Edelweiss Nifty Midcap150 Momentum 50 Index FundEdelweiss Mutual Fund | 17.30% | 7 |
| Tata Nifty Midcap 150 Momentum 50 Index FundTata Mutual Fund | 17.29% | 7 |
| Motilal Oswal BSE Midcap 150 Momentum 30 Index FundMotilal Oswal Mutual Fund | 16.40% | 5 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error. However, there can be no assurance or guarantee that the investment objectives of the scheme will be achieved.
Asset allocation
- Constituents of Nifty MidSmall Healthcare Index Fund - 95 -100 % Units of Liquid schemes and Money Market instruments - 0 - 5%
Type of scheme
An open ended fund replicating / tracking the Nifty MidSmall Healthcare Total Return Index
- BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back.
- Motilal Oswal Nifty MidSmall Healthcare Index Fund
- Risk level at launchRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very High
- New fund offer
- 29 Oct 2024 to 12 Nov 2024
- Units first allotted
- 19 Nov 2024
- Open for sale again
- 25 Nov 2024
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹500
Plans and codes
| Plan | AMFI code | ISIN | MUTF_IN | First NAV |
|---|---|---|---|---|
| Direct Growth | 153023 | INF247L01EA7 | MOTI_OSWA_NIFT_1V0RMRN | 25 Nov 2024 |
| Regular Growth | 153022 | INF247L01DT9 | MOTI_OSWA_NIFT_7UCSNI | 25 Nov 2024 |
This fund
- Scheme information document (opens in a new tab)The fund's objective, terms, costs and risks in full
Factsheet
- Factsheet september 2026 passive (opens in a new tab)Motilal Oswal Mutual Fund, Sep 2026
Statement of additional information
- SAI Motilal Oswal Mutual Fund (opens in a new tab)Motilal Oswal Mutual Fund, Oct 2026
Annual report
- Motilal mf index fund ar 2025-26 (opens in a new tab)Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf equity fund ar 2025-26 (opens in a new tab)Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf debt fund ar 2025-26 (opens in a new tab)Motilal Oswal Mutual Fund, Mar 2026
- Motilal mf etf fund ar 2025-26 (opens in a new tab)Motilal Oswal Mutual Fund, Mar 2026
Riskometer disclosure
- Riskometer Output July 2026 Portfolio Motilal Oswal Mutual Fund (opens in a new tab)Motilal Oswal Mutual Fund, Jul 2026
Portfolio overlap disclosure
- Portfolio overlap data as on september 30,2026 (opens in a new tab)Motilal Oswal Mutual Fund, Sep 2026